Abstract 1575P
Background
Exposure to secondhand smoke (SHS) can elevate the overall cancer risk for individuals who have never smoked. Smoke-free policies aim to protect non-smokers from the harmful effects of SHS and align with the guidelines set forth by the World Health Organization (WHO) Framework Convention on Tobacco Control. However, restrictions on smoking in outdoor public places are limited.
Methods
Between 2021 and 2024, the Spanish Association Against Cancer (SAAC) launched a program to enhance smoking prohibitions in outdoor areas. To do so, we first identified public places highly visited by smokers and vulnerable populations. Collaboration agreements were established with city halls, public organizations, and institutions interested in the project. These agreements involved advertising prohibiting smoking and vaping, smoke-free events, and training programs for the personnel responsible for enforcing these recommendations.
Results
Since the program's implementation, 358 collaboration agreements have been signed with 235 city halls through the 52 provinces of Spain. Most agreements (n=129, 36%) were launched to free urban and rural parks and green places from SHS. Other included outdoor sports centers and sports grounds (n=78,22%), universities (n=40,11%), and beaches (n=10, 3%). As a result of the good population and city halls' response to the initiative, the SAAC enforced the inclusion and regulation of outdoor smoke-free places in the new national comprehensive plan for the prevention of smoking.
Conclusions
Population-level initiatives to enforce smoke-free policies in outdoor places can result in new national legislation.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Spanish Association Against Cancer.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1501P - Sex-specific variation in symptoms presentation: Experience of an outpatient clinic integrated model between radiotherapy and palliative care
Presenter: Luca Tontini
Session: Poster session 10
1502P - Sexual dysfunction and quality of life in rectal cancer
Presenter: Fatih Kus
Session: Poster session 10
1503P - Spiritual needs in cancer patients: A cross-sectional study
Presenter: Diego Toloi
Session: Poster session 10
1546P - Use of ESMO-MCBS Scorecards in supporting funding decisions in private insurance
Presenter: Samantha Field
Session: Poster session 10
1547P - Time from approval to reimbursement of new cancer and non-cancer drugs: A comparative analysis between the US, England, Germany, and Switzerland (2011-2022)
Presenter: Camille Glaus
Session: Poster session 10
1548P - Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
Presenter: Jacob Reibel
Session: Poster session 10
1549P - Accelerating access to innovative oncology drugs: Insights from France's early access reform
Presenter: Tess Martin
Session: Poster session 10
1550P - Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence
Presenter: Sahar van Waalwijk van Doorn-Khosrovani
Session: Poster session 10
1551P - Breakthrough therapy cancer drugs and indications with FDA approval: Development time, innovation, trials, clinical benefit, epidemiology, and price
Presenter: Christoph Michaeli
Session: Poster session 10
1552P - Regulatory approval of novel immunotherapy for lymphoid neoplasm in the US, EU, and Japan
Presenter: Kensuke Matsuda
Session: Poster session 10